Please provide your email address to receive an email when new articles are posted on . NEW YORK — Results from the Multicenter Selective Lymphadenectomy Trial-I, or MSLT-I, should influence ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback